Results
|
|
1.
|
Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. MedStar authors:
- Howard, Barbara V
- Shara, Nawar M
- Wang, Hong
Year: 2013
Citation: - Journal of the American College of Cardiology. 61(7):728-37, 2013 Feb 19.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blum S, Cahill LE, Chiuve SE, Howard BV, Jensen MK, Levy AP, Mukamal KJ, Pai JK, Rexrode KM, Rimm EB, Shara NM, Wang H
|
|
|
2.
|
Complexity of the relation between hemoglobin A1C, diabetes mellitus, and progression of coronary narrowing in postmenopausal women. MedStar authors:
- Ahmad, Soha
- Lindsay, Joseph
- Silverman, Angela
- Xue, Zhenyi
Year: 2013
Citation: - American Journal of Cardiology. 111(6):793-9, 2013 Mar 15.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Ahmad S, Lindsay J, Silverman A, Xue Z
|
|
|
3.
|
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
- Fatemi, Omid
- Yuriditsky, Eugene
Citation: - American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
|
|
|
4.
|
|
|
|
5.
|
Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study. MedStar authors:
- Calhoun, Darren
- Howard, Barbara V
- Shara, Nawar M
- Umans, Jason G
- Wang, Hong
Year: 2011
Citation: - Diabetes Care. 34(9):1952-8, 2011 Sep.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Calhoun D, de Simone G, Devereux R, Howard BV, Lee ET, Shara NM, Umans JG, Wang H
|
|
|
6.
|
Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. MedStar authors:
- Aroda, Vanita R
- Fernandez, Stephen J
- Ratner, Robert E
Year: 2013
Citation: - Diabetes Technology & Therapeutics. 15(2):117-23, 2013 Feb.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Aroda VR, Conway BN, Fernandez SJ, Matter NI, Maynard JD, Orchard TJ, Ratner RE
|
|
|
7.
|
Cardiometabolic Syndrome in People With Spinal Cord Injury/Disease: Guideline-Derived and Nonguideline Risk Components in a Pooled Sample. MedStar authors:
- Groah, Suzanne L
- Ljungberg, Inger H
- Tinsley, Emily A
Year: 2016
Citation: - Archives of Physical Medicine & Rehabilitation. 97(10):1696-705, 2016 Oct
Institution:
- MedStar National Rehabilitation Network
- MedStar Washington Hospital Center
Department: - Physical Medicine and Rehabilitation
Medline publication type:
All authors: - Betancourt LF, Burns-Drecq PA, David M, Groah SL, Ljungberg IH, Mendez AJ, Nash MS, Tinsley EA, Tractenberg RE
|
|
|
8.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(9):1579-86, 2016 Sep
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T
|
|
|
9.
|
Fetal development in women with diabetes: imprinting for a life-time?. MedStar authors:
- Feghali, Maisa N
- Miodovnik, Menachem
Citation: - Journal of Maternal-Fetal & Neonatal Medicine. 25(1):11-4, 2012 Jan.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Obstetrics and Gynecology/Maternal-Fetal Medicine
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Dolan LM, Feghali M, Khoury JC, Miodovnik M, Rosenn B, Vandyke R
|
|
|
10.
|
|
|
|
11.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
|
12.
|
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. MedStar authors:
Year: 2016
Citation: - Diabetes Care. 39(11):1972-1980, 2016 Nov
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Bellido D, Bergenstal RM, Gonzalez-Galvez G, Guo H, LixiLan-L Trial Investigators, Niemoeller E, Rosenstock J, Souhami E, Takami A, Unger J, Wysham C
|
|
|
13.
|
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors:
Year: 2016
Citation: - Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J
|
|
|
14.
|
Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Citation: - Stroke. 43(3):720-6, 2012 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Best LG, Devereux RB, Howard BV, Karas MG, Kizer JR, Lee ET, Roman MJ, Umans JG, Whisnant JP, Wiebers DO
|
|
|
15.
|
Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study. MedStar authors:
- Howard, Barbara V
- Shara, Nawar M
- Umans, Jason G
Citation: - American Journal of Epidemiology. 176(10):865-74, 2012 Nov 15.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Crainiceanu CM, Francesconi KA, Goessler W, Gribble MO, Guallar E, Howard BV, Navas-Acien A, Shara NM, Silbergeld EK, Umans JG
|
|
|
16.
|
Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart Study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2016
Citation: - American Journal of Epidemiology. 184(11):806-817, 2016 Dec 01
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Best LT, Devereux RB, Fabsitz RR, Francesconi KA, Goessler W, Guallar E, Howard BV, Kuo CC, Navas-Acien A, Newman JD, Tellez-Plaza M, Umans JG
|
|
|
17.
|
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(8):2317-25, 2014 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F
|
|
|
18.
|
THE SYNERGY TO ENABLE GLYCEMIC CONTROL FOLLOWING EMERGENCY DEPARTMENT DISCHARGE PROGRAM FOR ADULTS WITH TYPE 2 DIABETES: STEP-DIABETES. MedStar authors:
- Dubin, Jeffrey S
- Magee, Michelle
- Mete, Mihriye
- Nassar, Carine M
- White, Keyoana
- Youssef, Gretchen A
Year: 2015
Citation: - Endocrine Practice. 21(11):1227-39, 2015 Nov.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Emergency Medicine
- Medicine/Endocrinology
- MedStar Diabetes Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Dubin JS, Magee MF, Mete M, Nassar CM, White K, Youssef GA
|
|
|
19.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|
